Actively Recruiting

Age: 32Years - 60Years
MALE
NCT07302503

Pilot Study Evaluating brainQuant's Ability to Detect Alterations in White Matter in Diffusion MRI, Indicative of Post-traumatic Lesions

Led by University Hospital, Strasbourg, France · Updated on 2025-12-24

80

Participants Needed

1

Research Sites

181 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease described in boxing, but also in contact sports such as American football. Soccer, due to repeated headers, could also be associated, albeit to a lesser degree, with the development of this type of pathology. Indeed, it has been shown that playing soccer can be accompanied by cognitive impairments, and neurodegenerative brain abnormalities have been described in neuropathology studies of former professional soccer players. Subradiological brain abnormalities have been found in multimodal MRI in various sports. Similarly, a decrease in cognitive performance has been described. The discovery of this type of anomaly in a population of professional footballers nearing the end of their careers could lead to: * The implementation of appropriate monitoring for professional footballers through early detection of lesions via MRI and cognitive disorders * The implementation of preventative measures for professional footballers, but also for amateur footballers from a very young age.

CONDITIONS

Official Title

Pilot Study Evaluating brainQuant's Ability to Detect Alterations in White Matter in Diffusion MRI, Indicative of Post-traumatic Lesions

Who Can Participate

Age: 32Years - 60Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male subject
  • Aged 32 to 60 years inclusive
  • Professional footballer nearing the end of their career or recently retired, or subject who has never regularly participated in sports that expose them to head trauma (particularly rugby, basketball, handball, American football, hockey, combat sports, etc.)
Not Eligible

You will not qualify if you...

  • Subject who expressed their opposition to participating in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Service d'Imagerie 2 - Réanimation - CHU de Strasbourg - France

Strasbourg, France, 67091

Actively Recruiting

Loading map...

Research Team

S

Stéphane KREMER, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here